H3C4: A Protein Targeted for Drug Development and Biomarker Research
H3C4: A Protein Targeted for Drug Development and Biomarker Research
H3C4, also known as H3C2, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the H3C family of proteins, which are known for their role in cell signaling and inflammation.
One of the key functions of H3C4 is its role in the regulation of inflammation. H3C4 has been shown to play a key role in the regulation of immune responses and inflammation, particularly in the context of chronic inflammatory disorders such as rheumatoid arthritis and chronic obstructive pulmonary disease (COPD).
In addition to its role in inflammation, H3C4 is also known for its potential as a drug target. Its unique structure and the various functions it is known to have make it an attractive target for drug development.
One of the reasons for H3C4's potential as a drug target is its structure. H3C4 is a small protein that has only four amino acid residues. This small size makes it relatively easy to manipulate, which is important for the development of small molecule drugs that can interact with its unique structure.
Another reason for H3C4's potential as a drug target is its location in the body. H3C4 is expressed in a variety of tissues throughout the body, which makes it an attractive target for drugs that can target a wide range of diseases. This can be particularly important for the development of drugs that work across multiple tissues and organs, such as drugs for cancer.
In addition to its potential as a drug target, H3C4 is also of interest to researchers as a potential biomarker. Its unique structure and functions make it an attractive candidate for use as a biomarker for a variety of diseases, including chronic inflammation and cancer.
One potential use for H3C4 as a biomarker is its ability to be targeted by small molecules. This can make it an attractive target for diagnostic tests that are designed to detect changes in the levels of H3C4 in certain tissues or fluids. This can be particularly useful for the detection of early-stage diseases when treatment is most effective.
Another potential use for H3C4 as a biomarker is its ability to be regulated by various signaling pathways. Its structure and functions make it an attractive target for drugs that can modulate its activity, which can be used to study the underlying mechanisms of its regulation. This can be particularly useful for the development of drugs that work by modulating signaling pathways that are involved in a wide range of diseases, including chronic inflammation and cancer.
Overall, H3C4 is an attractive protein that is being targeted by researchers as a potential drug target and biomarker. Its unique structure and functions make it an attractive target for the development of new therapies that can benefit a wide range of diseases.
Protein Name: H3 Clustered Histone 4
Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling
The "H3C4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H3C4 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8 | HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB | HBBP1 | HBD | HBE1 | HBEGF | HBG1 | HBG2 | HBM | HBO1 complex | HBP1 | HBQ1 | HBS1L | HBZ | HBZP1 | HCAR1
